120 related articles for article (PubMed ID: 38087265)
1. Additional primary malignancies in a Polish cohort of uveal melanoma patients: a review of 644 patients with long-term follow-up.
Wróblewska-Zierhoffer M; Paprzycka B; Kubiak A; Tomczyk Ł; Rospond-Kubiak I
BMC Ophthalmol; 2023 Dec; 23(1):506. PubMed ID: 38087265
[TBL] [Abstract][Full Text] [Related]
2. Non-ocular primary malignancies in patients with uveal melanoma: the Liverpool experience.
Heussen FM; Coupland SE; Kalirai H; Damato BE; Heimann H
Br J Ophthalmol; 2016 Mar; 100(3):356-9. PubMed ID: 26178903
[TBL] [Abstract][Full Text] [Related]
3. Additional malignancies and mortality in uveal melanoma: A 20-year follow-up of a Norwegian patient cohort.
Robsahm TE; Falk RS; Eide NA
Acta Ophthalmol; 2023 Sep; 101(6):696-704. PubMed ID: 36924309
[TBL] [Abstract][Full Text] [Related]
4. Uveal melanoma-associated cancers revisited.
Alfaar AS; Saad A; Elzouki S; Abdel-Rahman MH; Strauss O; Rehak M
ESMO Open; 2020 Nov; 5(6):e000990. PubMed ID: 33257317
[TBL] [Abstract][Full Text] [Related]
5. Uveal metastasis revealing lung cancer.
Meziani L; Cassoux N; Le Rouic LL; Gabriel CL; Dendale R; Sastre X; Catherine D; Livartowski A; Plancher C; Asselain B; Desjardins L
J Fr Ophtalmol; 2012 Jun; 35(6):420-5. PubMed ID: 22633214
[TBL] [Abstract][Full Text] [Related]
6. Clinical spectrum, treatment and outcomes of uveal melanoma in a tertiary centre.
Wong W; Sundar G; Chee C; Zhao PS; Rajagopalan R; Gopal L
Singapore Med J; 2019 Sep; 60(9):474-478. PubMed ID: 31197380
[TBL] [Abstract][Full Text] [Related]
7. The risk of other primary cancer in patients with uveal melanoma: a retrospective cohort study of a Canadian population.
Callejo SA; Al-Khalifa S; Ozdal PC; Edelstein C; Burnier MN
Can J Ophthalmol; 2004 Jun; 39(4):397-402. PubMed ID: 15327105
[TBL] [Abstract][Full Text] [Related]
8. The genetic basis of uveal melanoma.
Nielsen M; Dogrusöz M; Bleeker JC; Kroes WG; van Asperen CA; Marinkovic M; Luyten GP; Jager MJ
J Fr Ophtalmol; 2015 Jun; 38(6):516-21. PubMed ID: 25976137
[TBL] [Abstract][Full Text] [Related]
9. Cancer family history characterization in an unselected cohort of 121 patients with uveal melanoma.
Abdel-Rahman MH; Pilarski R; Ezzat S; Sexton J; Davidorf FH
Fam Cancer; 2010 Sep; 9(3):431-8. PubMed ID: 20157784
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma: Comparison with Institutional Controls.
Valsecchi ME; Orloff M; Sato R; Chervoneva I; Shields CL; Shields JA; Mastrangelo MJ; Sato T
Ophthalmology; 2018 Feb; 125(2):210-217. PubMed ID: 28935400
[TBL] [Abstract][Full Text] [Related]
11. Uveal melanoma: a study on incidence of additional cancers in the Swedish population.
Bergman L; Nilsson B; Ragnarsson-Olding B; Seregard S
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):72-7. PubMed ID: 16384946
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics of UM and Association of Metastasis of Uveal Melanoma with Congenital Oculocutaneous Melanosis in Asian Patients: Analysis of 1151 Consecutive Eyes.
Zhou N; Zhang R; Liu Y; Wei W
Ophthalmol Retina; 2021 Nov; 5(11):1164-1172. PubMed ID: 33444806
[TBL] [Abstract][Full Text] [Related]
13. Uveal melanoma: A pathologist's perspective and review of translational developments.
Schoenfield L
Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
[TBL] [Abstract][Full Text] [Related]
14. Risk factors, clinical outcomes, and natural history of uveal melanoma: a single-institution analysis.
Delgado-Ramos GM; Thomas F; VanderWalde A; King B; Wilson M; Pallera AM
Med Oncol; 2019 Jan; 36(2):17. PubMed ID: 30666496
[TBL] [Abstract][Full Text] [Related]
15. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
[TBL] [Abstract][Full Text] [Related]
16. [Multiple neoplasms in patients with uveal melanoma].
Caminal JM; Martínez J; Arias LL; Rubio M; Pujol O; Roca G; Arruga J
Arch Soc Esp Oftalmol; 2007 Sep; 82(9):535-40. PubMed ID: 17846942
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of ocular and oculodermal melanocytosis in Spanish population with uveal melanoma.
Carreño E; Saornil MA; Garcia-Alvarez C; Lopez-Lara F; De Frutos-Baraja JM; Almaraz A
Eye (Lond); 2012 Jan; 26(1):159-62. PubMed ID: 22020174
[TBL] [Abstract][Full Text] [Related]
18. Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma.
Schefler AC; Koca E; Bernicker EH; Correa ZM
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1541-1545. PubMed ID: 31065847
[TBL] [Abstract][Full Text] [Related]
19. Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis.
Frenkel S; Hendler K; Pe'er J
Isr Med Assoc J; 2009 May; 11(5):280-5. PubMed ID: 19637505
[TBL] [Abstract][Full Text] [Related]
20. Characterizations of uveal melanoma patients with three additional primary malignancies.
Eide NA; Faber RT; Garred Ø; Sørum Falk R; Robsahm TE
Acta Ophthalmol; 2024 Jan; ():. PubMed ID: 38229427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
